Indore-based surgeon Mohit Bhandari to receive prestigious International Surgeon Award in US; all you need to know about him
Mohit Bhandari
BHOPAL: Dr Mohit Bhandari, a surgeon based in Indore, Madhya Pradesh, is set to receive the prestigious International Surgeon Award at the upcoming American Society for Metabolic and Bariatric Surgery (ASMBS) Global Congress in Washington D.C.
, scheduled from 15 to 19 June 2025.
The award is regarded as one of the highest global honours in the field of metabolic and bariatric surgery.
Dr Bhandari has been chosen for this international recognition due to his development of the Self-Forming Magnetic Anastomosis Technique, an innovative surgical method that enhances safety, simplifies the procedure, and improves the effectiveness of bariatric surgeries.
This technique is especially helpful for patients with extreme obesity (weighing 200 kg or more), who are often not considered suitable for traditional surgical methods.
Having performed a record number of bariatric surgeries — claimed to be the highest in Asia — Dr Bhandari has significantly contributed to advancements in this medical field.
He has also introduced modern, non-surgical weight loss techniques in India, including Endoscopic Sleeve Gastroplasty (ESG) and the Allurion Balloon. His achievements have earned him a place in the World Book of Records.
'This award is not just a personal milestone but a recognition of India's growing expertise and research in advanced medical science,' claims Dr Bhandari.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
10 hours ago
- Indian Express
Mounjaro, Wegovy result in lower weight loss in the real world than clinical trials, says study: What explains this gap?
At a time when makers of weight loss drug Mounjaro are claiming that you can lose up to 22.5 per cent of your starting body weight over 72 weeks on its highest dose of 15 mg, a new study says the reality is quite the opposite. Researchers found that people on weight loss injectables shed fewer pounds in the real world than in clinical trials. In other words, this study indicates these drugs may not produce drastic weight loss in everyday settings. Researchers analysed data from 51,085 patients with a body mass index of 35 or greater and who were eligible for weight loss surgery and weight loss jabs. The team compared the three-year weight loss journey in 38,545 people prescribed semaglutide (sold under brand name Wegovy) and tirzepatide (Mounjaro) with 12,540 patients who underwent weight loss surgery. They found that those who underwent bariatric surgery had a significantly higher weight loss after two years, at 26.5%, compared with 5.7% for those prescribed semaglutide and tirzepatide. Semaglutide is a GLP1 receptor agonist (RA) which mimics the GLP 1 hormone and helps control blood sugar, reduce appetite and accelerate weight loss. Tirzepatide (Mounjaro) is a GLP1-RA cum GIP agonist. GIP has a role in food metabolism. The study will be presented at the American Society for Metabolic and Bariatric Surgery 2025 annual scientific meeting. 'The average patient on [GLP-1 RAs] in the real world is not getting the weight loss that we see in clinical trials,' says senior author Dr Karan Chhabra, Assistant Professor of Surgery & Population Health at Grossman School of Medicine, New York University. Does that mean that bariatric surgery will continue to be relevant? Listen in. 1) What could have been the reason for this discrepancy between weight loss in clinical trials and during real-time use of the drug? Though you have not done a data analysis on causes, what do you think went wrong? I think many patients either discontinued treatment or were not titrated (a method of assessing the concentration of a substance) up to the high doses needed for maximal weight loss. 2) Does this mean that we still need widespread studies on GLP 1 RAs? We need more real-world studies of GLP1 agonists – this study shows us that the clinical trial results do not always apply to real-world patients. Our team will be looking at this topic next – what can prescribers do to maximize the effectiveness of GLP1 RAs. 3) So far makers of weight loss drugs had claimed that their drugs were almost equivalent to bariatric surgery. How does this study challenge that perception? This study shows that in real world conditions, these drugs lead to far lesser weight loss than bariatric surgery for the average patient. 4) Who needs bariatric surgery? Rather, which set of people are more likely to benefit from bariatric surgery? Ultimately the treatment strategy should be tailored to individual patients' characteristics and preferences. Patients who do not want to be on lifelong medications, or who need 20 per cent weight loss to achieve their health goals, or who do not have insurance coverage for GLP1 RAs would be better served with surgery. 5) Do you see weight loss drugs having long-term efficacy? Weight loss drugs are effective for maintaining weight loss only for as long as they are taken. Many studies show that patients regain as much as 70 per cent of the weight lost when they stop taking these drugs. 6) Are weight loss drugs more hype than effect? No, this study underscores that these drugs are not a silver bullet but they can be highly effective when prescribed carefully by an expert physician. The goal is to get as many people to the right treatment (for obesity) as possible.
Time of India
2 days ago
- Time of India
BJ Medical College blaze: Nanny's presence of mind saves doctor's 2-year-old daughter after AI 171 crash
Nanny Takes Charge Child Was First to Be Rescued Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel A two-year-old girl was saved from a dangerous fire at the BJ Medical College hostel building in Ahmedabad, thanks to her mother's instinct and her nanny's quick actions. The fire had broken out after the crash of Air India flight AI 171 on to a TOI report, Dr Chanchal Bhandari, a cardiac anaesthetist at the UN Mehta Institute of Cardiology and Research Centre (UNMICRC), received a call from her daughter's nanny saying that smoke was coming from their building. Without wasting time, she rushed back home on her scooter, only to be stopped at the campus gate as rescue teams battled the Bhandari said it was the nanny's quick thinking that saved her daughter. 'She immediately took my daughter to a higher floor to avoid the smoke. When the rescue team asked her to come down, she carefully climbed down one floor while keeping my daughter safe from the smoke,' she to the heavy smoke and flames, residents were told to jump down onto a rescue mat. 'My baby's skin had turned black because of the smoke,' Dr Bhandari said, holding back tears. Her daughter was the first to be caught safely in the mat, followed by the nanny.'I'm thankful to God and to my nanny for saving her,' she child is now under observation and stable at the Civil Hospital campus, according to from TOI
Time of India
2 days ago
- Time of India
Indore-based surgeon Mohit Bhandari to receive prestigious International Surgeon Award in US; all you need to know about him
Mohit Bhandari BHOPAL: Dr Mohit Bhandari, a surgeon based in Indore, Madhya Pradesh, is set to receive the prestigious International Surgeon Award at the upcoming American Society for Metabolic and Bariatric Surgery (ASMBS) Global Congress in Washington D.C. , scheduled from 15 to 19 June 2025. The award is regarded as one of the highest global honours in the field of metabolic and bariatric surgery. Dr Bhandari has been chosen for this international recognition due to his development of the Self-Forming Magnetic Anastomosis Technique, an innovative surgical method that enhances safety, simplifies the procedure, and improves the effectiveness of bariatric surgeries. This technique is especially helpful for patients with extreme obesity (weighing 200 kg or more), who are often not considered suitable for traditional surgical methods. Having performed a record number of bariatric surgeries — claimed to be the highest in Asia — Dr Bhandari has significantly contributed to advancements in this medical field. He has also introduced modern, non-surgical weight loss techniques in India, including Endoscopic Sleeve Gastroplasty (ESG) and the Allurion Balloon. His achievements have earned him a place in the World Book of Records. 'This award is not just a personal milestone but a recognition of India's growing expertise and research in advanced medical science,' claims Dr Bhandari.
